Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group-Reference-Cited by-同舟云学术

Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group

Published:2013-06-05 Issue:3 Volume:162 Page:383-391
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Chen Jing¹,Lee Vincent²,Luo Cheng Juan¹,Chiang Alan Kwok Shing³,Hongeng Suradej⁴,Tan Poh Lin⁵,Tan Ah Moy⁶,Sanpakit Kleebsabai⁷,Li Chun Fu⁸,Lee Anselm Chi-wai⁹,Chua Hsin Chieh⁵,Okamoto Yasuhiro¹⁰

Affiliation:

1. Shanghai Jiao Tong University School of Medicine; Shanghai Children's Medical Centre; Shanghai; China

2. Prince of Wales Hospital; The Chinese University of Hong Kong; Hong Kong; Hong Kong

3. Queen Mary Hospital; Li Ka Shing Faculty of Medicine; The University of Hong Kong; Hong Kong; Hong Kong

4. Ramathibodi Hospital; Mahidol University Faculty of Medicine; Bangkok; Thailand

5. National University Health System; Singapore; Singapore

6. KK Women's and Children's Hospital; Singapore; Singapore

7. Siriraj hospital; Mahidol University Faculty of Medicine; Bangkok; Thailand

8. Nanfang Hospital; Southern Medical University; Guang Zhou; China

9. Mount Elizabeth Hospital; Singapore; Singapore

10. Kagoshima University Medical and Dental Hospital; Kagoshima; Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12405/fullpdf

Reference38 articles.

1. Long-term outcome after bone marrow transplantation for severe aplastic anemia;Ades;Blood,2004

2. Allogeneic stemcell transplantation for aplastic anemia;Armand;Biology of Blood and Marrow Transplantation,2007

3. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party;Bacigalupo;Bone Marrow Transplantation,2005

4. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party;Bacigalupo;Haematologica,2010

5. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor;Bensinger;Blood,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Conditioning Regimen and Graft-versus-Host Disease Prophylaxis on The Outcome of Haploidentical Peripheral Blood Stem Cell Transplantation for High-Risk Severe Aplastic Anemia in Children and Young Adults: A Report from the Pediatric Severe Aplastic Anemia Consortium of India;Transplantation and Cellular Therapy;2023-03

2. Thiotepa-based reduced toxicity conditioning in combination with post-transplant cyclophosphamide and mTOR inhibitor for heavily transfused acquired severe aplastic anemia in children and young adults: encouraging outcomes of a pilot study;Bone Marrow Transplantation;2022-11-24

3. Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes;Bone Marrow Transplantation;2022-06-22

4. High Failure-Free Survival after Unrelated Donor Peripheral Blood Stem Cell Transplantation in Pediatric Severe Aplastic Anemia;Transplantation and Cellular Therapy;2022-02

5. First‐line haploidentical stem cell transplantation in children and adolescents with severe aplastic anemia using mobilized peripheral blood as source of CD34+: Single‐institutional experience in a transplant center from northeast Mexico;Pediatric Transplantation;2021-07-13